Favipiravir Experience in COVID-19 Patients at a Tertiary Center Intensive Care Unit

OBJECTIVES: The aim of this study was to compare intensive care unit (ICU) and overall hospital mortality in patients treated with favipiravir and lopinavir-ritonavir for COVID-19. METHODS: Data were collected retrospectively between March 10 and May 10, 2020, from patients’ records admitted to ICU...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevinc, Sultan Acar, Cinar, Ayse Surhan, Basi, Nermin Balta, Metin, Seyhan, Yucel, Tugba, Islamoglu, Serkan, Altinay, Mustafa, Ozdemir, Haci Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Med Bull Sisli Etfal Hosp 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350063/
https://www.ncbi.nlm.nih.gov/pubmed/35990298
http://dx.doi.org/10.14744/SEMB.2021.35902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350063/
https://www.ncbi.nlm.nih.gov/pubmed/35990298
http://dx.doi.org/10.14744/SEMB.2021.35902

Ejemplares similares